UPDATE: Correction - Canaccord Genuity Maintains a 'Buy' on Incyte (INCY); Q2 and Guidance Raises Several Questions
Go back to UPDATE: Correction - Canaccord Genuity Maintains a 'Buy' on Incyte (INCY); Q2 and Guidance Raises Several Questions| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 119.52 -3.47 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $122.99 | 52 Week High | $118.49 | |||
| Open | $122.75 | 52 Week Low | $55.00 | |||
| Day High | $122.75 | P/E | N/A | |||
| Day Low | $118.44 | EPS | $-0.56 | |||
| Volume | 1,830,243 | |||||
